Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/ORCHPHARMA stock hub

NSE/ORCHPHARMA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ORCHPHARMAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35.7B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ORCHPHARMA

In the news

Latest news · NSE/ORCHPHARMA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.5

P25 24.9P50 32.4P75 45.7

Trailing P/E186.6

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC0.5

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ORCHPHARMA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

INR

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	736
Employees Change	-135%
Employees Change Percent	-15.5
Enterprise value	INR 37B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE191A01027
Last refreshed	2026-05-10
Market cap	INR 35.7B
Price	INR 702
Price currency	INR
Rev Per Employee	11,021,721.47x
Sector	Healthcare
Sic	2834
Symbol	nse/ORCHPHARMA
Website	https://www.orchidpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.53%
EV Earnings	194.16x
EV/EBITDA	82.81x
EV/Sales	4.56x
Forward P/E	28.54x
P/B ratio	2.8x
P/E ratio	186.59x
P/S ratio	4.4x
PE Ratio3 Y	60.83x
PE Ratio5 Y	62.56x
PEG ratio	1.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.88%
EBITDA Margin	5.28%
Gross margin	33.99%
Gross Profit	INR 2.8B
Gross Profit Growth	-20.88%
Gross Profit Growth Q	-30.72%
Gross Profit Growth3 Y	2.93%
Gross Profit Growth5 Y	4.4%
Net Income	INR 190.6M
Net Income Growth	-82.81%
Net Income Growth Years	5%
Pretax Margin	2.32%
Profit Margin	2.35%
Profit Per Employee	INR 258,986
Profitable Years	3
Roa5y	0.82
Roe5y	0.67
ROIC	0.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.64%
Cagr3y	21.14%
Cagr5y	-14.97%
EPS Growth	-82.76
EPS Growth Years	4
Revenue Growth	-10.02x
Revenue Growth Q	-4.64x
Revenue Growth Years	4x
Revenue Growth3 Y	8.55x
Revenue Growth5 Y	12.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.5B
Debt	INR 2.8B
Debt EBITDA	INR 6.52
Debt Equity	INR 0.22
Equity	INR 12.7B
Interest Coverage	0.5
Net Cash	INR -1.3B
Net Cash By Market Cap	INR -3.73
Net Debt EBITDA	INR 3.11
Net Debt Equity	INR 0.1
Tangible Book Value	INR 12.6B
Tangible Book Value Per Share	INR 248
WACC	7.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.63%
200-day SMA	706.6
3Y total return	77.79%
50-day SMA	565.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.54%
All Time High	2,654.3
All Time High Change	-73.55%
All Time High Date	2021-04-05
All Time Low	17.5
All Time Low Change	3,911.43%
All Time Low Date	2020-11-03
ATR	27.75
Beta	0.62
Beta1y	0.66
Beta2y	0.17
Ch YTD	-7.5
High	706
High52	899
High52 Date	2025-11-26
High52ch	-21.91%
Low	674.6
Low52	480
Low52 Date	2026-03-30
Low52ch	46.25%
Ma50ch	24.07%
Price vs 200-day SMA	-0.65%
RSI	78.86
RSI Monthly	47.04
RSI Weekly	53.46
Sharpe ratio	-0.22x
Sortino ratio	-0.17
Total Return	0.3%
Tr YTD	-7.5
Tr1m	35.42%
Tr1w	11.57%
Tr3m	3.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 71.1M
Operating Income Growth	-91.65
Operating margin	0.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,298,582%
Shares Institutions	24.41%
Shares Out	50,719,105
Shares Qo Q	0.01%
Shares Yo Y	-0.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	76,595.1x
Bv Per Share	251.5
Ch1m	35.42
Ch1w	11.57
Ch1y	-12.63
Ch3m	3.15
Ch3y	77.79
Ch5y	-55.54
Ch6m	-16.58
Change	2.93%
Change From Open	3.85
Close	682.1
Days Gap	-0.89
Depreciation Amortization	357,450,250
Dollar Volume	62,647,884
Earnings Date	2026-05-22
EBIT	INR 71.1M
EBITDA	INR 428.6M
EPS	INR 3.77
F Score	1
Fiscal Year End	March
Founded	1,992
Graham Number	145.43166
Graham Upside	-79.28
Income Tax	INR -2.3M
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Ma150	695.1
Ma150ch	1%
Ma20	592.3
Ma20ch	18.51%
Next Earnings Date	2026-05-22
Open	676
Position In Range	87.28
Price Date	2026-05-08
Price EBITDA	INR 83.25
Ptbv Ratio	2.84
Relative Volume	1.19x
Revenue	8,111,987,000x
Tax By Revenue	-0.03x
Tr6m	-16.58%
Volume	89,242

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/ORCHPHARMA pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/ORCHPHARMA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ORCHPHARMA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.4%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

NSE/ORCHPHARMA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.9

Above 70: short-term overbought

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ORCHPHARMA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ORCHPHARMA stock rating?

nse/ORCHPHARMA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ORCHPHARMA analysis?

The full report lives at /stocks/nse/ORCHPHARMA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ORCHPHARMA?

The latest report frames nse/ORCHPHARMA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ORCHPHARMA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.